Market revenue in 2021 | USD 1.2 million |
Market revenue in 2030 | USD 3.0 million |
Growth rate | 10.7% (CAGR from 2021 to 2030) |
Largest segment | Plants |
Fastest growing segment | Plants |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Animal, Plants, Synthetic |
Key market players worldwide | Amyris, Sophim, Kuraray Co Ltd, Croda International PLC, Arbe Robotics Ltd |
Plants was the largest segment with a revenue share of 75% in 2021. Horizon Databook has segmented the Russia squalene market based on animal, plants, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
Russia is anticipated to witness a gradual growth in the consumption of squalene over the forecast period. The pharmaceuticals and cosmetics industries are the key consumers of squalene in the country owing to advancements in pharmaceutical research activities taking place in Russia.
Thus, the surged consumption of squalene in the pharmaceuticals and cosmetics industries is anticipated to drive the growth of the market in the country over the forecast period. The pharmaceuticals industry in Russia grew from USD 20.91 billion in 2016 to USD 38.56 billion in 2021 owing to the continuously aging population in the country.
This is anticipated to drive the demand for squalene in this industry over the coming years. For domestic growth, different initiatives are undertaken by the Government of Russia. As of 2021, the government of the country invested USD 4 billion in the production of domestic pharmaceuticals in Russia.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account